The chairman of the University of Rochester Medical Center’s department of neurology is stepping down from that post, and stepping up duties as co-director of URMC’s Center for Translational Neuromedicine, officials said Tuesday.
Steven Goldman M.D. previously held the CTN position, while also serving as neurology chairman. Goldman serves with Co-Director Maiken Nedergaard M.D.
As part of the Clinical and Translational Science Institute, CTN concentrates on developing clinical applications for findings in basic neuroscience research that could lead to new treatments for diseases and neurodegenerative conditions, including such as multiple sclerosis, Parkinson’s, Huntington’s and Alzheimer’s diseases.
“(Goldman) has been instrumental in building a world-class neuro-oncology program, bolstered by a strong research program investigating the origins of brain tumors,” UR School of Medicine and Dentistry dean Mark Taubman M.D. said in a statement.
Taubman tapped Robert Holloway M.D. to serve as acting chairman of the neurology department. Holloway is to serve in that position while a committee conducts a national search for a permanent replacement for Goldman.
Holloway, who serves as assistant quality officer for Strong Memorial Hospital, is a member of the stroke and palliative care teams at the hospital and leads an American Medical Association stroke-care workgroup. He has served as vice chairman of the neurology department for the past six years.
(c) 2012 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail service@rbj.net.
eMail
View All Comments
Print
Reprints
